Prevalence of medication transfer errors in nephrology patients and potential risk factors

M M Ebbens1, H Errami2, D J A R Moes2

  • 1Leiden University Medical Center, Department of Clinical Pharmacy and Toxicology, Albinusdreef 2, 2333, ZA, Leiden, The Netherlands; Erasmus University Medical Center Rotterdam, Department of Hospital Pharmacy, Dr. Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands; St Jansdal Hospital, Department of Pharmacy, Wethouder Jansenlaan 90, 3844, DG, Harderwijk, The Netherlands.

Abstract

Insights

Medication transfer errors (MTE) are common in nephrology outpatient settings, affecting over 60% of patients. Patients taking more medications are at higher risk for these potentially harmful errors.

Area of Science:

  • Nephrology
  • Patient Safety
  • Pharmacology

Background:

  • Medication reconciliation is crucial during care transitions to prevent medication transfer errors (MTE).
  • MTE can lead to significant patient harm.
  • Identifying MTE risk factors can optimize targeted interventions.

Purpose of the Study:

  • Determine the prevalence of MTE in outpatient nephrology.
  • Investigate patient characteristics associated with MTE.
  • Analyze MTE types, potential harm, and involved medication classes.

Main Methods:

  • Retrospective observational cohort study at Leiden University Medical Center (Nov 2017-Apr 2018).
  • Medication reconciliation performed using the 'Medical Dashboard' electronic tool.
  • MTE defined as discrepancies between hospital system and reconciled medication lists. Multivariate logistic regression analyzed patient characteristics (age, sex, medication count, CKD-EPI).

Main Results:

  • 235 out of 380 patients (61.8%) experienced at least one MTE.
  • Average medication use was 10.3 per patient.
  • Increased number of medications significantly associated with MTE (OR 1.11; 95% CI 1.05-1.16). Age, sex, and kidney function showed no association.

Conclusions:

  • A high proportion (61.8%) of ambulatory nephrology patients experience MTE.
  • Higher medication burden in nephrology patients increases susceptibility to MTE.

Related Concept Videos

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
178
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
193
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
211
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
394
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
284
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
389